Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Effects of Glucocorticoids in Epidermal Keratinocytes


ABSTRACT: Glucocorticoids (GCs) have a long history of use as therapeutic agents for numerous skin diseases. Surprisingly, their specific molecular effects are largely unknown. To characterize GC action in epidermis, we compared the transcriptional profiles of primary human keratinocytes untreated and treated with dexamethasone (DEX) for 1, 4, 24, 48 and 72 hours using large-scale microarray analyses. The majority of genes were found regulated only after 24 hours and remained regulated throughout the treatment. In addition to expected anti-inflammatory genes, we found that GCs regulate cell fate, tissue remodeling, cell motility, differentiation and metabolism. GCs not only effectively block signaling by TNF-alpha and IL-1 but also by IFN-gamma, which was not previously known. Specifically, GCs suppress the expression of essentially all IFN-gamma-regulated genes, including IFN-gamma receptor and STAT-1. GCs also block STAT-1 activation and nuclear translocation. Unexpectedly, GCs have anti-apoptotic effects in keratinocytes by inducing the expression of anti-apoptotic and repressing pro-apoptotic genes. Consequently, GCs treatment blocked UV-induced apoptosis of keratinocytes. GCs have a profound effect on wound healing by inhibiting cell motility and the expression of pro-angiogenic factor VEGF. They play an important role in tissue remodeling and scar formation by suppressing the expression of TGF-beta-1 and -2, MMP1, 2, 9 and 10 and inducing TIMP-2. Finally, GCs promote terminal stages of epidermal differentiation while simultaneously inhibiting the early stages. These results provide new insights into the beneficial and adverse effects of GCs in epidermis, defining the participating genes and mechanisms that coordinate the cellular responses important for GC-based therapies. Human epidermal keratinocytes are grown in delipidized, phenolphtalein-free medium and left as controls or treated with 0.1μM dexamethasone. Time course of treated and parallel control samples over a 72 hr period was performed twice with independent batches of cells.

ORGANISM(S): Homo sapiens

SUBMITTER: Miki Blumenberg 

PROVIDER: E-GEOD-26487 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

Novel genomic effects of glucocorticoids in epidermal keratinocytes: inhibition of apoptosis, interferon-gamma pathway, and wound healing along with promotion of terminal differentiation.

Stojadinovic Olivera O   Lee Brian B   Vouthounis Constantinos C   Vukelic Sasa S   Pastar Irena I   Blumenberg Miroslav M   Brem Harold H   Tomic-Canic Marjana M  

The Journal of biological chemistry 20061109 6


Glucocorticoids (GCs) have a long history of use as therapeutic agents for numerous skin diseases. Surprisingly, their specific molecular effects are largely unknown. To characterize GC action in epidermis, we compared the transcriptional profiles of primary human keratinocytes untreated and treated with dexamethasone (DEX) for 1, 4, 24, 48, and 72 h using large scale microarray analyses. The majority of genes were found to be regulated only after 24 h and remained regulated throughout treatment  ...[more]

Similar Datasets

2007-10-26 | E-GEOD-4828 | biostudies-arrayexpress
2011-03-01 | E-GEOD-26523 | biostudies-arrayexpress
2014-04-25 | E-GEOD-57045 | biostudies-arrayexpress
2011-01-10 | E-GEOD-26521 | biostudies-arrayexpress
2013-09-05 | E-GEOD-50591 | biostudies-arrayexpress
2011-01-07 | GSE26487 | GEO
| PRJNA87247 | ENA
2007-10-26 | E-GEOD-440 | biostudies-arrayexpress
2018-12-16 | GSE48683 | GEO
2011-01-01 | E-GEOD-25164 | biostudies-arrayexpress